Fiduciary Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.7M | Sell |
13,964
-424
| -3% | -$433K | 0.18% | 83 |
|
|
2026
Q1 | $13.2M | Buy |
14,388
+323
| +2% | +$327K | 0.16% | 88 |
|
|
2025
Q4 | $15.1M | Sell |
14,065
-432
| -3% | -$413K | 0.17% | 87 |
|
|
2025
Q3 | $11.1M | Buy |
14,497
+3,375
| +30% | +$2.51M | 0.13% | 102 |
|
|
2025
Q2 | $8.67M | Buy |
11,122
+1,273
| +13% | +$989K | 0.11% | 118 |
|
|
2025
Q1 | $8.13M | Buy |
9,849
+509
| +5% | +$424K | 0.11% | 117 |
|
|
2024
Q4 | $7.21M | Buy |
9,340
+779
| +9% | +$645K | 0.1% | 130 |
|
|
2024
Q3 | $7.58M | Buy |
8,561
+522
| +6% | +$469K | 0.11% | 127 |
|
|
2024
Q2 | $7.28M | Buy |
8,039
+917
| +13% | +$734K | 0.11% | 124 |
|
|
2024
Q1 | $5.54M | Buy |
7,122
+89
| +1% | +$63.3K | 0.09% | 152 |
|
|
2023
Q4 | $4.1M | Sell |
7,033
-246
| -3% | -$144K | 0.07% | 165 |
|
|
2023
Q3 | $3.91M | Sell |
7,279
-377
| -5% | -$194K | 0.07% | 166 |
|
|
2023
Q2 | $3.59M | Buy |
7,656
+199
| +3% | +$83.5K | 0.06% | 177 |
|
|
2023
Q1 | $2.56M | Buy |
7,457
+624
| +9% | +$210K | 0.05% | 210 |
|
|
2022
Q4 | $2.5M | Buy |
6,833
+463
| +7% | +$164K | 0.05% | 214 |
|
|
2022
Q3 | $2.06M | Buy |
6,370
+327
| +5% | +$104K | 0.04% | 226 |
|
|
2022
Q2 | $1.96M | Sell |
6,043
-116
| -2% | -$34.8K | 0.04% | 233 |
|
|
2022
Q1 | $1.76M | Sell |
6,159
-251
| -4% | -$64.6K | 0.03% | 273 |
|
|
2021
Q4 | $1.77M | Sell |
6,410
-146
| -2% | -$37K | 0.03% | 269 |
|
|
2021
Q3 | $1.51M | Sell |
6,556
-205
| -3% | -$50.6K | 0.03% | 273 |
|
|
2021
Q2 | $1.55M | Sell |
6,761
-2,431
| -26% | -$488K | 0.03% | 273 |
|
|
2021
Q1 | $1.72M | Sell |
9,192
-206
| -2% | -$40.3K | 0.03% | 261 |
|
|
2020
Q4 | $1.59M | Sell |
9,398
-751
| -7% | -$112K | 0.03% | 266 |
|
|
2020
Q3 | $1.5M | Sell |
10,149
-1,272
| -11% | -$197K | 0.04% | 246 |
|
|
2020
Q2 | $1.88M | Buy |
11,421
+65
| +0.6% | +$9.98K | 0.05% | 219 |
|
|
2020
Q1 | $1.57M | Buy |
11,356
+364
| +3% | +$50K | 0.05% | 217 |
|
|
2019
Q4 | $1.45M | Sell |
10,992
-335
| -3% | -$38.8K | 0.03% | 238 |
|
|
2019
Q3 | $1.27M | Sell |
11,327
-245
| -2% | -$27.3K | 0.03% | 247 |
|
|
2019
Q2 | $1.28M | Buy |
11,572
+870
| +8% | +$102K | 0.03% | 236 |
|
|
2019
Q1 | $1.39M | Buy |
10,702
+569
| +6% | +$69.2K | 0.04% | 221 |
|
|
2018
Q4 | $1.17M | Buy |
10,133
+75
| +0.7% | +$8.38K | 0.04% | 217 |
|
|
2018
Q3 | $1.08M | Hold |
10,058
| – | – | 0.03% | 242 |
|
|
2018
Q2 | $858K | Buy |
10,058
+587
| +6% | +$48.2K | 0.03% | 268 |
|
|
2018
Q1 | $733K | Sell |
9,471
-101
| -1% | -$8.13K | 0.02% | 279 |
|
|
2017
Q4 | $808K | Buy |
9,572
+163
| +2% | +$13.9K | 0.02% | 274 |
|
|
2017
Q3 | $805K | Sell |
9,409
-950
| -9% | -$77.9K | 0.02% | 273 |
|
|
2017
Q2 | $852K | Sell |
10,359
-50
| -0.5% | -$4.08K | 0.03% | 267 |
|
|
2017
Q1 | $876K | Sell |
10,409
-11,732
| -53% | -$940K | 0.03% | 273 |
|
|
2016
Q4 | $1.63M | Sell |
22,141
-12,305
| -36% | -$916K | 0.05% | 204 |
|
|
2016
Q3 | $2.77M | Sell |
34,446
-40
| -0.1% | -$3.2K | 0.09% | 165 |
|
|
2016
Q2 | $2.72M | Sell |
34,486
-28
| -0.1% | -$2.11K | 0.1% | 163 |
|
|
2016
Q1 | $2.48M | Buy |
34,514
+237
| +0.7% | +$17.9K | 0.09% | 166 |
|
|
2015
Q4 | $2.89M | Sell |
34,277
-1,688
| -5% | -$140K | 0.12% | 139 |
|
|
2015
Q3 | $3.01M | Sell |
35,965
-214
| -0.6% | -$18.1K | 0.14% | 126 |
|
|
2015
Q2 | $3.02M | Sell |
36,179
-1,034
| -3% | -$78.8K | 0.13% | 136 |
|
|
2015
Q1 | $2.7M | Buy |
37,213
+500
| +1% | +$35.6K | 0.11% | 144 |
|
|
2014
Q4 | $2.53M | Buy |
36,713
+513
| +1% | +$34.6K | 0.11% | 145 |
|
|
2014
Q3 | $2.35M | Hold |
36,200
| – | – | 0.1% | 140 |
|
|
2014
Q2 | $2.25M | Hold |
36,200
| – | – | 0.1% | 143 |
|
|
2014
Q1 | $2.13M | Sell |
36,200
-2,404
| -6% | -$134K | 0.09% | 145 |
|
|
2013
Q4 | $1.97M | Buy |
38,604
+600
| +2% | +$30K | 0.09% | 147 |
|
|
2013
Q3 | $1.91M | Hold |
38,004
| – | – | 0.09% | 144 |
|
|
2013
Q2 | $1.87M | Buy |
+38,004
| New | +$2.07M | 0.09% | 146 |
|
Other funds holding LLY
Fiduciary Trust's LLY Position: Q2 2026 in Review
Fiduciary Trust reduced its Eli Lilly (LLY) stake by 2.9% in Q2 2026, selling an estimated $433K and leaving 13,964 shares worth $16.7M. The position accounts for 0.18% of the portfolio, ranked #83.
Fiduciary Trust first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Fiduciary Trust held 13,964 shares of Eli Lilly worth $16.7M as of Q2 2026.
- Fiduciary Trust sold 424 Eli Lilly shares in Q2 2026, an estimated $433K.
- Eli Lilly made up 0.18% of Fiduciary Trust's portfolio in Q2 2026, its #83 holding.
- Fiduciary Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.